Matches in SemOpenAlex for { <https://semopenalex.org/work/W1913275399> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W1913275399 endingPage "174" @default.
- W1913275399 startingPage "167" @default.
- W1913275399 abstract "Abstract Two activities have been identified for the immunosuppressive metabolite of leflunomide, A77 1726: inhibition of dihydroorotate dehydrogenase (DHO-DHase), an enzyme involved in the biosynthesis of pyrimidine nucleotides (PyN); and inhibition of protein tyrosine kinases. The in vitro potency of A77 1726 as a DHO-DHase inhibitor is reported to be 10- to 500-fold greater than as a tyrosine kinase inhibitor. These observations suggested that the immunosuppressive efficacy of leflunomide in vivo is related to inhibition of DHO-DHase. However, observations that patients with disorders in the PyN synthetic pathway are not overtly immunodeficient militate against this hypothesis. We investigated the effects of leflunomide in vivo and report that amelioration of lymphoproliferative and autoimmune diseases in MRL/MpJ-lpr/lpr (lpr/lpr) mice by leflunomide is not accompanied by reduced PyN concentrations in lymph node cells. Our hypothesis that lymphocytes could salvage serum uridine to counter the effects of reduced PyN synthesis in vivo was supported by in vitro studies. Finally, we observed that amelioration of disease correlated with a reduction of tyrosine phosphorylated proteins in lymph node cells of lpr/lpr mice. These observations suggest that the primary mechanism by which leflunomide prevents autoimmune and lymphoproliferative diseases in lpr/lpr mice is not depletion of PyN, but correlates with reduced tyrosine phosphorylation concentrations in lymph node cells." @default.
- W1913275399 created "2016-06-24" @default.
- W1913275399 creator A5006986996 @default.
- W1913275399 creator A5016092861 @default.
- W1913275399 creator A5052690820 @default.
- W1913275399 creator A5064181653 @default.
- W1913275399 creator A5071781435 @default.
- W1913275399 creator A5072427454 @default.
- W1913275399 creator A5090706571 @default.
- W1913275399 date "1997-07-01" @default.
- W1913275399 modified "2023-10-17" @default.
- W1913275399 title "In vivo mechanism by which leflunomide controls lymphoproliferative and autoimmune disease in MRL/MpJ-lpr/lpr mice." @default.
- W1913275399 doi "https://doi.org/10.4049/jimmunol.159.1.167" @default.
- W1913275399 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9200452" @default.
- W1913275399 hasPublicationYear "1997" @default.
- W1913275399 type Work @default.
- W1913275399 sameAs 1913275399 @default.
- W1913275399 citedByCount "59" @default.
- W1913275399 countsByYear W19132753992012 @default.
- W1913275399 countsByYear W19132753992013 @default.
- W1913275399 countsByYear W19132753992014 @default.
- W1913275399 countsByYear W19132753992015 @default.
- W1913275399 countsByYear W19132753992016 @default.
- W1913275399 countsByYear W19132753992017 @default.
- W1913275399 countsByYear W19132753992018 @default.
- W1913275399 countsByYear W19132753992021 @default.
- W1913275399 countsByYear W19132753992022 @default.
- W1913275399 crossrefType "journal-article" @default.
- W1913275399 hasAuthorship W1913275399A5006986996 @default.
- W1913275399 hasAuthorship W1913275399A5016092861 @default.
- W1913275399 hasAuthorship W1913275399A5052690820 @default.
- W1913275399 hasAuthorship W1913275399A5064181653 @default.
- W1913275399 hasAuthorship W1913275399A5071781435 @default.
- W1913275399 hasAuthorship W1913275399A5072427454 @default.
- W1913275399 hasAuthorship W1913275399A5090706571 @default.
- W1913275399 hasBestOaLocation W19132753991 @default.
- W1913275399 hasConcept C150903083 @default.
- W1913275399 hasConcept C181199279 @default.
- W1913275399 hasConcept C185592680 @default.
- W1913275399 hasConcept C203014093 @default.
- W1913275399 hasConcept C207001950 @default.
- W1913275399 hasConcept C26291073 @default.
- W1913275399 hasConcept C2775905006 @default.
- W1913275399 hasConcept C2779865431 @default.
- W1913275399 hasConcept C2781059491 @default.
- W1913275399 hasConcept C55493867 @default.
- W1913275399 hasConcept C71924100 @default.
- W1913275399 hasConcept C86803240 @default.
- W1913275399 hasConceptScore W1913275399C150903083 @default.
- W1913275399 hasConceptScore W1913275399C181199279 @default.
- W1913275399 hasConceptScore W1913275399C185592680 @default.
- W1913275399 hasConceptScore W1913275399C203014093 @default.
- W1913275399 hasConceptScore W1913275399C207001950 @default.
- W1913275399 hasConceptScore W1913275399C26291073 @default.
- W1913275399 hasConceptScore W1913275399C2775905006 @default.
- W1913275399 hasConceptScore W1913275399C2779865431 @default.
- W1913275399 hasConceptScore W1913275399C2781059491 @default.
- W1913275399 hasConceptScore W1913275399C55493867 @default.
- W1913275399 hasConceptScore W1913275399C71924100 @default.
- W1913275399 hasConceptScore W1913275399C86803240 @default.
- W1913275399 hasIssue "1" @default.
- W1913275399 hasLocation W19132753991 @default.
- W1913275399 hasOpenAccess W1913275399 @default.
- W1913275399 hasPrimaryLocation W19132753991 @default.
- W1913275399 hasRelatedWork W1964717435 @default.
- W1913275399 hasRelatedWork W1982399678 @default.
- W1913275399 hasRelatedWork W1998680008 @default.
- W1913275399 hasRelatedWork W2048569921 @default.
- W1913275399 hasRelatedWork W2050685671 @default.
- W1913275399 hasRelatedWork W2054218135 @default.
- W1913275399 hasRelatedWork W2060604323 @default.
- W1913275399 hasRelatedWork W2074354044 @default.
- W1913275399 hasRelatedWork W3209367156 @default.
- W1913275399 hasRelatedWork W4300338748 @default.
- W1913275399 hasVolume "159" @default.
- W1913275399 isParatext "false" @default.
- W1913275399 isRetracted "false" @default.
- W1913275399 magId "1913275399" @default.
- W1913275399 workType "article" @default.